Jerome Thiery (Jérôme Thiery)

Years Active: 2019-2022
Publications (10 Years): 5

INSERM

Paris Descartes University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Oct 01 2012

France

CRCN :: U1186

Harvard Medical School

United States

Postdoctoral research fellow :: Immune Disease Institute and Program in Cellular and Molecular Medicine at Children's Hospital

Education History

Paris Descartes University

France

PHD

Publications

Jerome Thiery
Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions. Exploration of targeted anti-tumor therapy 3 (5) (2022)
Linda Ziani, Stéphanie Buart, Salem Chouaib, Jerome Thiery
Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity. Oncoimmunology 10 (1) (2021)
Stéphanie Buart, Stéphane Terry, M'boyba Khadija Diop, Philippe Dessen, Sophie Couvé, Abdérémane Abdou, Julien Adam, Jerome Thiery, Pierre Savagner, Salem Chouaib
The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation. Cancers 13 (15) (2021)
Goutham Hassan Venkatesh, Pamela Bravo, Walid Shaaban Moustafa Elsayed, Francis Amirtharaj, Bartosz Wojtaś, Raefa Abou Khouzam, Husam Hussein Nawafleh, Sandeep Mallya, Kapaettu Satyamoorthy, Philippe Dessen, Filippo Rosselli, Jerome Thiery, Salem Chouaib
Hypoxia increases mutational load of breast cancer cells through frameshift mutations. Oncoimmunology 9 (1) (2020)
Marie Chollat-Namy, Thouraya Ben Safta-Saadoun, Djazia Haferssas, Guillaume Meurice, Salem Chouaib, Jerome Thiery
The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell death & disease 10 (10) (2019)

Jerome Thiery.css-eqlu8i{font-size:small;padding-left:4px;} (Jérôme Thiery)